AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
SRx Health Solutions Appoints Joshua Epstein to Board of Directors
ByAinvest
Monday, Oct 6, 2025 2:05 pm ET1min read
• SRx Health Solutions appoints Joshua Epstein to Board of Directors and Compensation Committee. • Epstein brings expertise in digital health and data analytics. • Forward-looking statements in press release. • Private Securities Litigation Reform Act of 1995 applies.
SRx Health Solutions (NYSE American: SRXH) has announced the appointment of Joshua Epstein to its Board of Directors and Compensation Committee. The announcement, made on October 1, 2025, reflects a strategic move to bolster the company's governance structure with Epstein's expertise in digital health and data analytics [1].The press release, issued by SRx Health Solutions, Inc., states that Epstein's appointment is part of a straightforward addition to the company's governance structure. The announcement includes forward-looking statements, which are subject to the Private Securities Litigation Reform Act of 1995 [1]. These statements highlight the company's expectations about future events and financial trends, emphasizing that actual results may differ from projections.
The press release also includes standard contact information for further inquiries. Investors are advised to refer to the company's filings with the SEC for additional risk factors and forward-looking statements.
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet